Instem's Alphadas Software Suite Goes Live at BioKinetic Europe's N. Ireland Unit.
M2 PHARMA-January 20, 2017-Instem's Alphadas Software Suite Goes Live at BioKinetic Europe's N. Ireland Unit
(C)2017 M2 COMMUNICATIONS
- US-based early development healthcare market IT specialist Instem's Alphadas software suite has gone live at BioKinetic Europe's Phase I unit located in Belfast, N. Ireland, the company said.
BioKinetic Europe conducts Phase I --III studies on behalf of pharmaceutical companies in Europe, Asia and the United States.
Alphadas is mobile, schedule-driven, and provides real-time bedside or station based direct data capture that virtually eliminates paper-based data.
BioKinetic users access Alphadas over the web via Instem's professionally managed online hosting infrastructure, which is being used by drug developers, contract research organisations, universities, research institutes and government agencies around the world.
Accessed on-site or via the Instem Cloud, the Alphadas software solution suite is a proactive early phase CTMS, eSource data capture and reporting system.
BioKinetic is a FPM (Faculty of Pharmaceutical Medicine) approved educational training unit, with a range of Principal Investigators and Clinical Research Professionals with experience and expertise across all therapeutic areas.
Instem is a supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 20, 2017|
|Previous Article:||Semerjian to Head Specialty Care International Region, Global Franchises at Ipsen.|
|Next Article:||Gonitro to Participate in US NIH-Sponsored Comparative Effectiveness ISCHEMIA Clinical Trial.|